Imaging Response to Immunotherapy and Radiation Therapy in Patients With Liver Metastases

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Total Enrollment

1 participants

Study Classification

OBSERVATIONAL

Study Start Date

2018-08-02

Study Completion Date

2019-12-12

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Patients will be imaged with MRE at the time of the RT planning MRI, prior to the induction of RT and immunotherapy. Research imaging will be in addition to standard imaging studies performed at time points consistent with the standard of care (at the time of the RT planning MRI and the first clinical follow-up). An additional MRE exam will be performed at the end of treatment outside the standard of care imaging.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

MRE for Assessment of Histopathological Growth Patterns in Colorectal Liver Metastases

NCT06208397

Metastatic Colorectal Cancer

RECRUITING

PSMA PET/MRI or PSMA PET/CT for Evaluation of Liver Cancer

NCT04310540

Hepatocellular Carcinoma

COMPLETED EARLY_PHASE1

Evaluation of the Signa Excite 3.0 T MRI Excite for Detection and Characterization of Liver Lesions

NCT00527891

Liver Cancer

COMPLETED

Early Therapy Response Monitoring in Melanoma Patients Using PET/MRI

NCT03132090

Malignant Melanoma Stage IV

UNKNOWN NA

A Study of Radiation Toxicity in the Liver Using MRI-Based Perfusion

NCT01210027

Liver Cancer

COMPLETED

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Liver Metastases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Magnetic Resonance Elastography

rapidly developing technology for quantitatively assessing the mechanical properties of tissue, using externally applied mechanical waves

Intervention Type OTHER

Other Intervention Names

Discover alternative or legacy names that may be used to describe the listed interventions across different sources.

MRE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Age ≥ 18 years
* Diagnosis of solid cancers with the presence of one or more liver metastases
* Minimum metastasis diameter ≥ 2 cm
* Planning to receive radiation therapy with immunotherapy
* Willingness to participate in mandatory imaging studies at Mayo Clinic Rochester